120
Participants
Start Date
September 19, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2025
adjuvant type
ropivacaine combined with adjuvant
Taipei Veterans General Hospital, Taipei
Taipei Veterans General Hospital, Taiwan
OTHER_GOV